Yao-WenChengMD

PubMed

• 3 citations
  Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis.
  Amy Yu, Nghiem B Ha, Bingyan Shi, Yao-Wen Cheng, Uma Mahadevan
  Clinical Gastroenterology and Hepatology. 2023-11-01
• 1 citations
  Racial Disparities in Endoscopy Cancellations During the COVID-19 Pandemic.
  Connie W Wang, Richard Mclean I, Yao-Wen Cheng, Stephanie Kim, Jonathan Terdiman
  Digestive Diseases and Sciences. 2023-03-01
• 69 citations
  Fecal Microbiota Transplantation.
  Yao-Wen Cheng, Monika Fischer
  Clinics in Colon and Rectal Surgery. 2023-03-01

Journal Articles

• The Role of Fecal Microbiota Transplantation in Elderly Patients  
  Cheng Y, Fischer M., Practical Gastroenterology, 8/1/2017
• Fecal Microbiota Transplantation for Recurrent or Refractory Clostridium difficile Infection in Inflammatory Bowel Disease  
  Yao-Wen Cheng, Monika Fischer, Practical Gastroenterology, 1/2017

Abstracts/Posters

• Characteristics Associated with Decreased Relapse After Proton Pump Inhibitor Discontinuation in Patients with Gastroesophageal Reflux Disease
  Katherine Cheng, Yao-Wen Cheng, Digestive Diseases Week, Chicago, IL, 5/2017
• The Benefits of a Dedicated Paracentesis Clinic for Outpatients with Cirrhosis and Ascites
  Cheng Y, Shah A, Ghabril M, Berry WA, Sandrasegaran K, Curtis L, Lammert C, Chalasani NP, Orman ES, Digestive Diseases Week, Chicago, IL, 5/2017
• Cost Savings Following Provider Education: Indications for Acid Suppression Therapy
  Burgin C, Cheng Y, Cheng K, Zerr A, IUPUI Research Day, Indianapolis, IN, 4/2017
• Smoking, obesity, and abrupt discontinuation of acid suppression therapy associated with relapse in chronic outpatient users.
  Cheng Y, Cheng K, Burgin C, Zerr A, American College of Physicians Internal Medicine Meeting 2017, San Diego, CA, 3/2017
• ACE-inhibitor induced visceral angioedema: an under-recognized cause of recurrent abdominal pain
  Yao-Wen Cheng, Nicholas Crews, Timothy Imler, American College of Physicians Indiana Chapter Meeting, Carmel, IN, 11/2016
• Changes in mortality, colectomy, and length of hospital stay after implementation of inpatient fecal microbiota transplantation program for severe clostridium difficile.
  Mustapha E, Cheng Y, Rogers N, Sagi S, Bohm M, Xu H, Fischer M, American College of Gastroenterology, Las Vegas, NV, 10/2016
• Sequential fecal microbiota transplant protocol: a promising alternative to colectomy in severe and severe/complicated clostridium difficile
  Cheng Y, Xu H, Rogers N, Sagi S, Bohm M, Fischer M, American College of Gastroenterology, Las Vegas, NV, 10/1/2016
• Join now to see all

Lectures

• Fecal Microbiota Transplant Decreases Mortality in Patients with Severe and Severe-Complicated Clostridium difficile Infection, Including Cases Not Eligible for Colectomy 
  World Congress of Gastroenterology at ACG2017 - 10/18/2017
• Fecal Microbiota Transplant Decreases Mortality and Colectomy in Severe and Complicated Clostridium difficile Infection 
  Indiana University Department of Medicine Grand Rounds - 5/2017
• Characteristics Associated with Decreased Relapse after Proton Pump Inhibitor Discontinuation in Patients with Gastroesophageal Reflux Disease 
  Indiana University Department of Medicine Grand Rounds - 5/2017
• Over-use of proton pump inhibitors decreased with guideline-based information sheet. 
  American College of Physicians Internal Medicine Meeting 2017 - 3/2017
• Join now to see all